Recent Finacing
Recent Raise
iQure Pharma is a Princeton-based biotech developing therapeutics for neuropathic pain, epilepsy, and neurodegenerative diseases, advancing preclinical candidates iQ-007 and iQ-008 through NIH PSPP/HEAL screening.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at iQure Pharma.